About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 768190, 10 pages
http://dx.doi.org/10.5402/2012/768190
Clinical Study

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

1Division of Chemotherapy and Clinical Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
2Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
3New Frontiers Research Laboratories, Toray Industries, Inc., 10-1 Tebiro, Kanagawa, Kamakura 248-8555, Japan
4Bio Science Department, Research and Development Center, Mitsui Knowledge Industry Co., Ltd., 2-7-14 Higashinakano, Nakano-Ku, Tokyo 164-8555, Japan
5Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Received 17 September 2012; Accepted 2 October 2012

Academic Editors: A. E. Bilsland, B. Comin-Anduix, G. Ferrandina, and S. Holdenrieder

Copyright © 2012 Michiko Takakura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Michiko Takakura, Akira Yokomizo, Yoshinori Tanaka, et al., “Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer,” ISRN Oncology, vol. 2012, Article ID 768190, 10 pages, 2012. doi:10.5402/2012/768190